halobetasol propionate 0.1 MG/ML / tazarotene 0.45 MG/ML Topical Lotion
RxNorm concept 2166089, clinical drug (scd). Prescribable name: halobetasol propionate 0.01 % / tazarotene 0.045 % Topical Lotion.
- RxCUI
- 2166089
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2166089 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
halobetasol propionate 0.01 % / tazarotene 0.045 % Topical Lotion
Related concepts
- halobetasol propionate 0.1 MG/ML (SCDC, consists of)
- tazarotene 0.45 MG/ML (SCDC, consists of)
- Topical Lotion (DF, has dose form)
- halobetasol propionate 0.1 MG/ML / tazarotene 0.45 MG/ML Topical Lotion [Duobrii] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2166089 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2166089 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2166089. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.